Tanimoto Sarina's Form 4 filing
ARS Pharmaceuticals, Inc. (SPRY) · filed Aug 21, 2025
- Accession no.
- 0001415889-25-022638
- Filed
- Aug 21, 2025
- Trade date
- Aug 19-20, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $703.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tanimoto SarinaCIK 0001951291 | Officer (CHIEF MEDICAL OFFICER), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2025 | Common Stock | SSaleDisposed | −12,344 | $14.03 | −$173,186.32 | 1,285,103 | Indirect | |
| Aug 20, 2025 | Common Stock | SSaleDisposed | −37,656 | $14.09 | −$530,573.04 | 1,247,447 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.